Home / Inspections / 1217534

FDA Inspection 1217534 — Osiris Therapeutics Inc

Osiris Therapeutics Inc — FEI 3006638648

The FDA completed an inspection of Osiris Therapeutics Inc on August 7, 2023 in Columbia, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 7, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Columbia, MD (United States)

Facility

Other inspections at this facility

  • 1095336 (NAI Mon May 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 967937 (NAI Thu Apr 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 834769 (VAI Tue Jun 04 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 736419 (NAI Thu Jul 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources